Keebeck Wealth Management purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 28,212 shares of the company’s stock, valued at approximately $3,650,000.
Other institutional investors have also recently bought and sold shares of the company. Frazier Financial Advisors LLC acquired a new stake in Merck KGaA during the 2nd quarter worth about $25,000. Kilter Group LLC acquired a new position in shares of Merck KGaA in the second quarter worth about $62,000. Addison Advisors LLC acquired a new position in shares of Merck KGaA in the second quarter worth about $90,000. Hara Capital LLC purchased a new position in shares of Merck KGaA in the second quarter worth approximately $110,000. Finally, Comprehensive Financial Planning Inc. PA purchased a new position in shares of Merck KGaA in the second quarter worth approximately $134,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Up 0.7%
MKGAF stock opened at $163.21 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company’s 50 day simple moving average is $162.62 and its 200-day simple moving average is $148.46.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
